Researchers have been excited about the medication , a innovative dual agonist showing remarkable results in early trials for weight management. It functions by targeting both pathways : GLP-1 and GIP, which , when stimulated, help regulate hunger and boost calorie burn. Early observations suggest considerable size reduction and likely improveme… Read More